The difference is the form, the dose, and what each is licensed to treat: Wegovy is a weekly injection for weight loss, and Rybelsus is a daily tablet for type 2 diabetes
The STEP trials for semaglutide, for instance, enrolled thousands of participants and demonstrated average weight loss of approximately 15% of body weight over 68 weeks
The American Psychological Association suggests relaxing, meditating, and physical activity to manage stressors
Studies show patients regain roughly 60% of the weight they lost within the first year , with research projecting a return to pre-treatment weight within about 1.5 to 2 years
Achieve your body transformation goals: GLP-1 medications for weight loss Key takeaways GLP-1 medications, like Wegovy, Ozempic, and Saxenda, mimic a natural hormone that regulates appetite, insulin release, and digestion